ProMIS Neurosciences Inc.
PMN · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Williams Eugene: Form 4
Insider disclosure · Filed · Report period 04 Nov 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001374339 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PMN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Suite 200, 1920 Yonge Street, Toronto, Ontario, Canada, M4S 3E2
- Incorporated in
- Canada (Federal Level)
- Fiscal year end
- 31 December
- Former names on EDGAR
- AMORFIX LIFE SCIENCES LTD (to 03 Nov 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields